Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Small lymphocytic lymphoma; CLL; Melanoma; Immune checkpoint inhibitors; Pembrolizumab; PD-1 inhibitor;
مقالات ISI لوسمی مزمن لنفوئیدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوسمی مزمن لنفوئیدی; Constrictive pericarditis; Chronic lymphocytic leukemia; Multimodality imaging;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Young; Richter's transformation;
Keywords: لوسمی مزمن لنفوئیدی; chronic lymphocytic leukemia; CLL; primary care; targeted therapies; tumor biology;
Keywords: لوسمی مزمن لنفوئیدی; 5-Aza; 5-Aza-2-deoxycytidine; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BIR; baculoviral inhibitor of apoptosis repeat; CAD; caspase-activated deoxyribonuclease; CDK; cyclin-dependent kinase; cIAP; cellular inhibitor of apoptosis; CL
Keywords: لوسمی مزمن لنفوئیدی; VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; granuloma annulare; granulomatous dermatitis; immunocompromised district; immunodeficiency; immunocompromise; immunosuppression; isotopic response; locus minoris resistentiae; postherpetic isotopic response; Wolf's isotopic r
Keywords: لوسمی مزمن لنفوئیدی; chronic lymphocytic leukemia; CLL; primary care; targeted therapies; tumor biology;
Keywords: لوسمی مزمن لنفوئیدی; EV; extracellular vesicles; ILVs; intraluminal vesicles; BMSCs; bone marrow stromal cells; AML; acute myeloid leukemia; CML; chronic myelogenous leukemia; CLL; chronic lymphocytic leukemia; ALL; acute lymphoblastic leukemia; EGF; epidermal growth factor;
Keywords: لوسمی مزمن لنفوئیدی; Nuclei segmentation; Genetic algorithm; Wavelet transform; H&E-stained histological images; Chronic lymphocytic leukemia;
Keywords: لوسمی مزمن لنفوئیدی; Intravenous immunoglobulin; Subcutaneous immunoglobulin; Hypogammaglobulinemia; Chronic lymphocytic leukemia; Lymphoma; Myeloma; Hematopoietic cell transplantation; Anaphylaxis; CAR-T therapy; B-cell signaling and survival pathways.;
Keywords: لوسمی مزمن لنفوئیدی; ABC; activated-B Cell; BTK; Bruton's tyrosine kinase; CNS; Central nervous system; CLL; chronic lymphocytic leukemia; DLBCL; Diffuse Large B-cell lymphoma; DAB; diaminobenzidin; DNMT; DNA methyltransferase; GO; gene ontology; GCB; germinal center cell lik
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; CLL; Ibrutinib; Idelalisib; Venetoclax; Targeted therapy;
Keywords: لوسمی مزمن لنفوئیدی; AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: لوسمی مزمن لنفوئیدی; 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: لوسمی مزمن لنفوئیدی; FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Tumor microenvironment; Adenosine;
Keywords: لوسمی مزمن لنفوئیدی; ocular adnexal lymphoma; intraocular lymphoma; extranodal marginal zone lymphoma; diffuse large B-cell lymphoma; non-Hodgkin's lymphoma; chronic lymphocytic leukemia; small cell lymphoma;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Cost-effectiveness; Ibrutinib; Markov model; Obinutizumab;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; DNA methylation; Histone modification; Outcome; Prognosis;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Maintenance; Anti-CD20 antibodies; Kinase-inhibitors; Lenalidomide; Long-term treatment;
Keywords: لوسمی مزمن لنفوئیدی; ADP; mono-adenosine diphosphate; ATP; adenosine triphosphate; BC; breast cancer; BMI; body mass index; Cdks; cyclin-dependent kinases; C.I.; confidence interval; CLL; chronic lymphocytic leukemia; CRP; C-reactive protein; CtBPs; mammalian COOH-terminal bi
Keywords: لوسمی مزمن لنفوئیدی; Leucémie lymphoïde chronique; Panniculite nécrosante; Cryofibrinogène; Chronic lymphocytic leukemia; Necrotizing panniculitis; Cryofibrinogenemia;
Keywords: لوسمی مزمن لنفوئیدی; Blood brain barrier; Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; High-dose chemotherapy; Mantle cell lymphoma;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; CLL; Older adults; Targeted therapy;
Keywords: لوسمی مزمن لنفوئیدی; Apoptosis/survival proteins; Chronic lymphocytic leukemia; ZAP-70;
Keywords: لوسمی مزمن لنفوئیدی; γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: لوسمی مزمن لنفوئیدی; ET-1; Endothelin-1; CLL; Chronic Lymphocytic Leukemia; ETAR; Endothelin receptor type A; TLR; Toll-like receptor; PBMC; peripheral blood mononuclear cell; GAPDH; Glyceraldehyde 3-phosphate dehydrogenase; MSP; Methylation Specific PCR; FBS; Fetal bovine se
Keywords: لوسمی مزمن لنفوئیدی; Anaplastic large cell lymphoma; Breast; Breast lymphoma; Burkitt lymphoma; Chloroma; Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; Granulocytic sarcoma; Hematolymphoid neoplasms; High grade B-cell lymphoma; Lymphoma; Marginal zone lymphoma;
Keywords: لوسمی مزمن لنفوئیدی; ASH; American Society of Hematology; ATAP; amphipathic tail-anchoring peptide; BAD; BCL-2-associated death promoter protein; BAK; BCL-2 homologous antagonist killer; BAX; BCL-2-associated X protein; BCL-2; B-cell lymphoma 2; BCL-w (BCL2L2); BCL-2-like pro
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Population-based; Treatment; Survival; FISH; Chemoimmunotherapy;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Janus kinases; STAT3; Ruxolitinib; Cholesterol; Lipoproteins; Lysosomal lipase; HMGCR; Nuclear receptors;
Keywords: لوسمی مزمن لنفوئیدی; APTMS; 3-aminopropyltriethoxysilane; 8-OHdG; 8-hydroxydeoxyguanosine; BRE; Bio-recognition element; BRCA-1; Breast cancer 1 gene; CNTs; Carbon nanotubes; CLL; Chronic lymphocytic leukemia; EIS; Electrochemical impedance spectroscopy; ELISA; Enzyme linked
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Minimal residual disease; Cell-based diagnostics; Automated gating; Cluster analysis; Flow cytometry; FLOCK;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; KIs; Non-Hodgkin lymphoma; RT;
Keywords: لوسمی مزمن لنفوئیدی; AML; acute myeloid leukemia; CAK; CDK-activating kinase; CDK; cyclin-dependent kinases; CLL; chronic lymphocytic leukemia; CT; RNA polymerase II C-terminal domain; DLT; dose-limiting toxicities; DSIF; DRB-sensitivity inducing factor; ER; estrogen Receptor
Keywords: لوسمی مزمن لنفوئیدی; Lenalidomide; Chronic lymphocytic leukemia; Nonmyeloablative; Allogeneic; Transplantation;
Keywords: لوسمی مزمن لنفوئیدی; Curcumin; Chronic lymphocytic leukemia; Nuclear factor kappa B; STAT3; Akt; Apoptosis;
Keywords: لوسمی مزمن لنفوئیدی; AML; acute myeloid leukemia; BRCA; breast cancer; BRCC3; BRCA1/BRCA2-Containing Complex Subunit 3; C; constant; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; CSC; cancer stem-like cell; EGFR; epidermal growth factor receptor; EMT; epit
Keywords: لوسمی مزمن لنفوئیدی; Anticoagulation; Atrial flutter; Chronic lymphocytic leukemia; Mantle cell lymphoma; Waldenstrom macroglobulinemia;
Keywords: لوسمی مزمن لنفوئیدی; AE; adverse event; AML; acute myeloid leukemia; APC; anaphase promoting complex; CLL; chronic lymphocytic leukemia; CPC; chromosomal passenger complex; CR; complete response; CRi; complete remission with incomplete blood count recovery; FDA; Food and Drug
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Proliferation center; Bone marrow pattern
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; IgVH mutation; ZAP70; DNA biosensor; Electrochemical impedance spectroscopy;
Keywords: لوسمی مزمن لنفوئیدی; Richter syndrome; Chronic lymphocytic leukemia; Diffuse large B-cell lymphoma; NOTCH1; Subset 8;
Keywords: لوسمی مزمن لنفوئیدی; Richter transformation; Chronic lymphocytic leukemia; Hodgkin lymphoma; Epstein-Barr virus; Clonality; ZAP-70; Reed-Sternberg cell;
Keywords: لوسمی مزمن لنفوئیدی; BEN; bendamustine; CI; combination index; CLB; chlorambucil; CLL; chronic lymphocytic leukemia; Cyclo; cyclophosphamide; dADO; deoxyadenosine; Del; deletion; DHE; dihydroethidium; DiOC6; 3,3â²-dihexyloxacarbocyanine iodide; DMSO; dimethyl sulfoxide; DR;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Allogeneic hematopoietic cell transplantation; BCR inhibitors; BCL-2 inhibitors;
Keywords: لوسمی مزمن لنفوئیدی; Chronic Lymphocytic Leukemia; Chemotherapy Treatment; Autoimmune disease development; Machine learning;
Keywords: لوسمی مزمن لنفوئیدی; Chronic lymphocytic leukemia; Transformation; Richter's syndrome;
Keywords: لوسمی مزمن لنفوئیدی; Ag; antigen; bnAb; broadly neutralizing anti-HIV Ig; CLL; chronic lymphocytic leukemia; EBV; Epstein Barr virus; GBM; glomerular basement membrane; GN; glomerulonephritis; GP; Goodpasture; GPS; GP syndrome; HC; heavy chain; HCDR3; heavy chain complementar